Skip to main content

Weight-loss drugs like Ozempic are in such huge demand that spending on them will hit $100B by 2035

By Fortune  
   September 25, 2023

The global market for novel weight-loss drugs like Novo Nordisk A/S's Ozempic and Wegovy is poised to reach $100 billion by 2035 as patients start to understand the efficacy of the medications.

Full story

Get the latest on healthcare leadership in your inbox.